EUVIMEDEUVIMED entdecken
Crossref

Serology and histology in Sjögren’s syndrome diagnosis: a retrospective accuracy study

Luiz Claudio Viegas-Costa, Reid Friesen, Hollis Lai, Timothy McGaw

Clinical Rheumatology · 2025

DOI: 10.1007/s10067-025-07302-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Rheumatology, 2025. Verfasst von Luiz Claudio Viegas-Costa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dentistry-Division of Oral Medicine, Oral Pathology and Radiology, and Division of Dental Hygiene, Faculty of Medicine and Dentistry, U…. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Antibodies, Antinuclear, Salivary Glands, Minor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Sjögren's syndrome (SS) presents complex diagnostic challenges due to its multi-organ involvement, often leading to misdiagnosis, which can result in unnecessary treatments, elevated healthcare costs, and significant impacts on patient quality of life. Accurate diagnosis is therefore critical, utilising ACR/EULAR criteria that include both labial minor salivary gland (LMSG) biopsy and anti-SSA antibodies. METHODS: This retrospective study analysed medical records of 87 adults suspected of primary SS, who underwent both anti-SSA serology and LMSG biopsy. We evaluated the diagnostic accuracy of these tests under existing ACR/EULAR criteria and a newly proposed 'modified ACR/EULAR criteria - ClinDx'. Statistical analysis included Pearson's chi-square test for the association between test results and disease status and receiver operating characteristic (ROC) curves to assess the sensitivity and specificity of the diagnostic models. RESULTS: Utilising ACR/EULAR criteria, 40 patients were diagnosed with SS, while 47 were categorised as non-diseased. The ClinDx criteria application resulted in 32 SS diagnoses and 55 non-diseased classifications, highlighting discrepancies in patients with low anti-SSA titers (< 200 MFU). Statistical analysis confirmed a significant association (p < 0.001) between test results and disease status, indicating the robustness of the modified criteria in enhancing diagnostic accuracy. CONCLUSIONS: This study underscores the utility of integrating serological tests and histological biopsies in diagnosing SS. While anti-SSA antibodies provide a good preliminary screening tool, the specificity of LMSG biopsies is indispensable. Refining both serological and histological assessments per ClinDx criteria can improve diagnostic accuracy, aiding in better management of SS and reducing healthcare burdens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sjogren's SyndromeAntibodies, AntinuclearSalivary Glands, MinorHumansRetrospective StudiesFemaleMiddle AgedMaleAdultBiopsyAgedSensitivity and SpecificityROC CurveSalivary Glands

Stichwörter der Autor:innen

Accuracy studyRheumatologic diseasesSalivary gland diseasesSjögren’s syndrome

Substanzen

Antibodies, AntinuclearSS-A antibodies

Autor:innen und Institutionen

  • Department of Dentistry-Division of Oral Medicine, Oral Pathology and Radiology, and Division of Dental Hygiene, Faculty of Medicine and Dentistry, University of Alberta, Room 5-357 Edmonton Clinic Health Academy, 11405…

Zitieren

APA

Viegas-Costa, L. C., Friesen, R., Lai, H., & McGaw, T. (2025). Serology and histology in Sjögren’s syndrome diagnosis: a retrospective accuracy study. Clinical Rheumatology. https://doi.org/10.1007/s10067-025-07302-5

Vancouver

Viegas-Costa LC, Friesen R, Lai H, McGaw T. Serology and histology in Sjögren’s syndrome diagnosis: a retrospective accuracy study. Clinical Rheumatology. 2025. doi:10.1007/s10067-025-07302-5

BibTeX
@article{ViegasCosta2025,
  author = {Viegas-Costa, Luiz Claudio and Friesen, Reid and Lai, Hollis and McGaw, Timothy},
  title = {Serology and histology in Sjögren’s syndrome diagnosis: a retrospective accuracy study},
  journal = {Clinical Rheumatology},
  year = {2025},
  doi = {10.1007/s10067-025-07302-5}
}
Kostenlos starten →